Obinutuzumab effective for lupus nephritis

IF 29.4 1区医学 Q1 RHEUMATOLOGY

Nature Reviews Rheumatology Pub Date : 2025-03-07 DOI:10.1038/s41584-025-01237-6

Sarah Onuora

引用次数: 0

Abstract

In a phase III trial, the addition of obinutuzumab to standard therapy for lupus nephritis led to an increase in the proportion of patients with a complete renal response.

查看原文本刊更多论文

Obinutuzumab对狼疮性肾炎有效

在一项III期试验中，将obinutuzumab添加到狼疮性肾炎的标准治疗中，导致肾脏完全缓解的患者比例增加。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Nature Reviews Rheumatology 医学-风湿病学

CiteScore

29.90

自引率

0.90%

发文量

137

审稿时长

6-12 weeks

期刊介绍： Nature Reviews Rheumatology is part of the Nature Reviews portfolio of journals. The journal scope covers the entire spectrum of rheumatology research. We ensure that our articles are accessible to the widest possible audience.